Association of CETP Gene Polymorphisms and Haplotypes with Cardiovascular Risk

Cholesteryl ester transfer protein (CETP) is known to influence HDL-C levels, potentially altering the profile of HDL subfractions and consequently cardiovascular risk (CVR). This study aimed to investigate the effect of five single-nucleotide polymorphisms (SNPs; rs1532624, rs5882, rs708272, rs7499892, and rs9989419) and their haplotypes (H) in the CETP gene on 10-year CVR estimated by the Systematic Coronary Risk Evaluation (SCORE), the Framingham Risk Score for Coronary Heart Disease (FRSCHD) and Cardiovascular Disease (FRSCVD) algorithms. Adjusted linear and logistic regression analyses were used to investigate the association of SNPs and 10 haplotypes (H1–H10) on 368 samples from the Hungarian general and Roma populations. The T allele of rs7499892 showed a significant association with increased CVR estimated by FRS. H5, H7, and H8 showed a significant association with increased CVR based on at least one of the algorithms. The impact of H5 was due to its effect on TG and HDL-C levels, while H7 showed a significant association with FRSCHD and H8 with FRSCVD mediated by a mechanism affecting neither TG nor HDL-C levels. Our results suggest that polymorphisms in the CETP gene may have a significant effect on CVR and that this is not mediated exclusively by their effect on TG and HDL-C levels but also by presently unknown mechanisms.

[1]  G. Mensah,et al.  The Global Burden of Cardiovascular Diseases and Risk: A Compass for Future Health. , 2022, Journal of the American College of Cardiology.

[2]  A. Vercesi,et al.  Novel Role of CETP in Macrophages: Reduction of Mitochondrial Oxidants Production and Modulation of Cell Immune-Metabolic Profile , 2022, Antioxidants.

[3]  N. Alp,et al.  Obicetrapib Lowers LDL-C in Patients Taking High Intensity Statins - Results from the ROSE Clinical Trial , 2022, Journal of Clinical Lipidology.

[4]  R. Ádány,et al.  The profile of HDL-C subfractions and their association with cardiovascular risk in the Hungarian general and Roma populations , 2022, Scientific Reports.

[5]  M. Hedayati,et al.  Review of Laboratory Methods to Determine HDL and LDL Subclasses and Their Clinical Importance , 2022, Reviews in cardiovascular medicine.

[6]  M. Martínez-ríos,et al.  The rs4783961 and rs708272 genetic variants of the CETP gene are associated with coronary artery disease, but not with restenosis after coronary stenting , 2021, Archivos de cardiologia de Mexico.

[7]  A. Hingorani,et al.  Cholesteryl ester transfer protein (CETP) as a drug target for cardiovascular disease , 2021, Nature Communications.

[8]  N. Câmara,et al.  Cholesterol-Ester Transfer Protein Alters M1 and M2 Macrophage Polarization and Worsens Experimental Elastase-Induced Pulmonary Emphysema , 2021, Frontiers in Immunology.

[9]  R. Ádány,et al.  Comparative risk assessment for the development of cardiovascular diseases in the Hungarian general and Roma population , 2021, Scientific Reports.

[10]  J. Hare,et al.  The Presence of Cholesteryl Ester Transfer Protein (CETP) in Endothelial Cells Generates Vascular Oxidative Stress and Endothelial Dysfunction , 2021, Biomolecules.

[11]  V. Dogra,et al.  Association of ESR1 (rs2234693 and rs9340799), CETP (rs708272), MTHFR (rs1801133 and rs2274976) and MS (rs185087) polymorphisms with Coronary Artery Disease (CAD) , 2020, BMC Cardiovascular Disorders.

[12]  R. Ádány,et al.  Prevalence of Insulin Resistance in the Hungarian General and Roma Populations as Defined by Using Data Generated in a Complex Health (Interview and Examination) Survey , 2020, International journal of environmental research and public health.

[13]  R. Ádány,et al.  The Effect of Haplotypes in the CETP and LIPC Genes on the Triglycerides to HDL-C Ratio and Its Components in the Roma and Hungarian General Populations , 2020, Genes.

[14]  J. Finger,et al.  European Health Interview Survey (EHIS) 2 – Background and study methodology , 2019, Journal of health monitoring.

[15]  I. Benseñor,et al.  High-density Lipoprotein-cholesterol Subfractions and Coronary Artery Calcium: The ELSA-Brasil Study. , 2019, Archives of medical research.

[16]  F. Rosendaal,et al.  The association of genetic variants in the cholesteryl ester transfer protein gene with hemostatic factors and a first venous thrombosis , 2019, Journal of thrombosis and haemostasis : JTH.

[17]  E. Fisher,et al.  HDL and Reverse Cholesterol Transport. , 2019, Circulation research.

[18]  R. Ádány,et al.  Generalizability and applicability of results obtained from populations of European descent regarding the effect direction and size of HDL-C level-associated genetic variants to the Hungarian general and Roma populations. , 2019, Gene.

[19]  E. Ashley,et al.  Cardiovascular disease: The rise of the genetic risk score , 2018, PLoS medicine.

[20]  B. Nordestgaard,et al.  Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: Two prospective cohort studies. , 2017, Atherosclerosis.

[21]  R. Ádány,et al.  Genetic factors exist behind the high prevalence of reduced high-density lipoprotein cholesterol levels in the Roma population. , 2017, Atherosclerosis.

[22]  C. Granger,et al.  Evacetrapib and Cardiovascular Outcomes in High‐Risk Vascular Disease , 2017, The New England journal of medicine.

[23]  K. Hatakeyama.  CETP Activity: A Link between Lipid Metabolism and Coagulation System , 2016, Journal of atherosclerosis and thrombosis.

[24]  G. Collins,et al.  Prediction models for cardiovascular disease risk in the general population: systematic review , 2016, British Medical Journal.

[25]  N. Câmara,et al.  CETP Lowers TLR4 Expression Which Attenuates the Inflammatory Response Induced by LPS and Polymicrobial Sepsis , 2016, Mediators of inflammation.

[26]  Q. Niu,et al.  Association between Eight Functional Polymorphisms and Haplotypes in the Cholesterol Ester Transfer Protein (CETP) Gene and Dyslipidemia in National Minority Adults in the Far West Region of China , 2015, International journal of environmental research and public health.

[27]  Mitchell J. Machiela,et al.  LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants , 2015, Bioinform..

[28]  P. Gu,et al.  CETP gene polymorphisms and risk of coronary atherosclerosis in a Chinese population , 2013, Lipids in Health and Disease.

[29]  T. Ashavaid,et al.  Association of CETP and LIPC Gene Polymorphisms with HDL and LDL Sub-fraction Levels in a Group of Indian Subjects: A Cross-Sectional Study , 2013, Indian Journal of Clinical Biochemistry.

[30]  Nima Hosseinzadeh,et al.  Heritability of the metabolic syndrome and its components in the Tehran Lipid and Glucose Study (TLGS). , 2012, Genetics research.

[31]  A. Kontush,et al.  High-Density Lipoprotein (HDL) Particle Subpopulations in Heterozygous Cholesteryl Ester Transfer Protein (CETP) Deficiency: Maintenance of Antioxidative Activity , 2012, PloS one.

[32]  John Spertus,et al.  Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study , 2012, The Lancet.

[33]  D. Johns,et al.  Anacetrapib, a Novel CETP Inhibitor: Pursuing a New Approach to Cardiovascular Risk Reduction , 2012, Clinical pharmacology and therapeutics.

[34]  S. Alabakovska,et al.  Cholesteryl ester transfer protein, low density lipoprotein particle size and intima media thickness in patients with coronary heart disease. , 2011, Bosnian journal of basic medical sciences.

[35]  N. Barzilai,et al.  Cholesteryl ester transfer protein (CETP) genotype and reduced CETP levels associated with decreased prevalence of hypertension. , 2010, Mayo Clinic proceedings.

[36]  Jennifer G. Robinson,et al.  Dalcetrapib: a review of Phase II data , 2010, Expert opinion on investigational drugs.

[37]  J. Danesh,et al.  Major lipids, apolipoproteins, and risk of vascular disease. , 2009, JAMA.

[38]  J. Després,et al.  HDL particle size and the risk of coronary heart disease in apparently healthy men and women: the EPIC-Norfolk prospective population study. , 2009, Atherosclerosis.

[39]  M. Pencina,et al.  General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study , 2008, Circulation.

[40]  José A Fernández,et al.  Plasma cholesteryl ester transfer protein and blood coagulability , 2007, Thrombosis and Haemostasis.

[41]  A. Tall,et al.  The failure of torcetrapib: was it the molecule or the mechanism? , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[42]  Joan Valls,et al.  SNPStats: a web tool for the analysis of association studies , 2006, Bioinform..

[43]  D. Rader,et al.  Macrophage reverse cholesterol transport: key to the regression of atherosclerosis? , 2006, Circulation.

[44]  L. Kleinberg,et al.  The association of common SNPs and haplotypes in the CETP and MDR1 genes with lipids response to fluvastatin in familial hypercholesterolemia. , 2006, Atherosclerosis.

[45]  Peter Libby,et al.  The forgotten majority: unfinished business in cardiovascular risk reduction. , 2005, Journal of the American College of Cardiology.

[46]  Charles C Schwartz,et al.  Lipoprotein cholesteryl ester production, transfer, and output in vivo in humans Published, JLR Papers in Press, May 16, 2004. DOI 10.1194/jlr.M300511-JLR200 , 2004, Journal of Lipid Research.

[47]  A. Zwinderman,et al.  The relationship between cholesteryl ester transfer protein levels and risk factor profile in patients with familial hypercholesterolemia. , 2004, Atherosclerosis.

[48]  A. Zwinderman,et al.  Cholesteryl ester transfer protein concentration is associated with progression of atherosclerosis and response to pravastatin in men with coronary artery disease (REGRESS) , 2004, European journal of clinical investigation.

[49]  M Nauck,et al.  Haplotypes of the cholesteryl ester transfer protein gene predict lipid-modifying response to statin therapy , 2003, The Pharmacogenomics Journal.

[50]  H. Tunstall-Pedoe,et al.  Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. , 2003, European heart journal.

[51]  D. Rader,et al.  Cholesteryl Ester Transfer Protein: A Novel Target for Raising HDL and Inhibiting Atherosclerosis , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[52]  J. Kim,et al.  Studies on the plasma lipid profiles, and LCAT and CETP activities according to hyperlipoproteinemia phenotypes (HLP). , 2001, Atherosclerosis.

[53]  D. Levy,et al.  Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.

[54]  C. Barbagallo,et al.  Lipoprotein Profile and High-Density Lipoproteins: Subfractions Distribution in Centenarians , 1998, Gerontology.

[55]  Riesen Wf.  [Lipoprotein (a)--link between lipid metabolism and coagulation system?]. , 1991 .

[56]  M. Goddard,et al.  Cholesterol-Ester Transfer Protein Alters M1 and M2 Macrophage Polarization and Worsens Experimental Elastase-Induced Pulmonary Emphysema , 2022 .

[57]  OUP accepted manuscript , 2022, European Heart Journal - Cardiovascular Pharmacotherapy.

[58]  OUP accepted manuscript , 2021, European Heart Journal.

[59]  OUP accepted manuscript , 2021, Cardiovascular Research.

[60]  N. Kohno,et al.  Associations between small dense LDL, HDL subfractions (HDL2, HDL3) and risk of atherosclerosis in Japanese-Americans. , 2012, Journal of atherosclerosis and thrombosis.

[61]  A. Dukát,et al.  HDL subfractions analysis: a new laboratory diagnostic assay for patients with cardiovascular diseases and dyslipoproteinemia. , 2011, Neuro endocrinology letters.

[62]  G. Moneta,et al.  Major Lipids, Apolipoproteins, and Risk of Vascular Disease , 2010 .

[63]  D. Gordon,et al.  High-Density Lipoprotein Cholesterol and Cardiovascular Disease , 2005 .

[64]  S. Grundy,et al.  National Cholesterol Education Program Third Report of the National Cholesterol Education Program ( NCEP ) Expert Panel on Detection , Evaluation , and Treatment of High Blood Cholesterol in Adults ( Adult Treatment Panel III ) Final Report , 2022 .

[65]  D. Gordon,et al.  High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies. , 1989, Circulation.

[66]  K. Shadan,et al.  Available online: , 2012 .